Differential expression of miR-128 in memory T cells of patients with severe hemophilia A with and without inhibitors

Silvia Spena, Andrea Cairo, Emanuela Pappalardo, Calogero C. Tedesco, Roberta Gualtierotti, Flora Peyvandi · 2026

Read Differential expression of miR-128 in memory T cells of patients with severe hemophilia A with and without inhibitors by Silvia Spena, Andrea Cairo, Emanuela Pappalardo, Calogero C. Tedesco, Roberta Gualtierotti, Flora Peyvandi (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13343139.txt.

Description

Silvia Spena and co-authors measure a small RNA molecule in blood cells of people with severe hemophilia A. Their 2026 study asks whether this molecule, miR-128, differs between patients who develop inhibitors and those who do not. Inhibitors are antibodies that block the clotting factor treatment, and they arise in about thirty percent of patients.

Forty-five patients took part, grouped by whether their inhibitor was lasting, passing, or absent. Levels of miR-128 ran higher in blood cells of patients with inhibitors. The gap was largest in memory T cells of patients with lasting inhibitors, at nearly four times the level. The authors suggest this RNA helps steer T cell growth in the inhibitor response.

Catalog record

CREATORSilvia Spena, Andrea Cairo, Emanuela Pappalardo, Calogero C. Tedesco, Roberta Gualtierotti, Flora Peyvandi
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE21 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13343139

Browse the full library · About the Tower of Babel